![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Doggrell Sheila A
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.4, Iss.3, 2003-03, pp. : 407-409
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Use of ACE‐Inhibitors after Myocardial Infarction
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations
By Davie A.P.
PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Zhang Zefeng Mahoney Elizabeth M.
American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)